<table sstyle="width:80%" align="center" border=1>
<tr>
<th>mv</th>
<th>dw</th>
<th>HMMCrowd</th>
</tr>
<tr>
<td width=33%>
[180, 210] body weight, BP (mercury sphygmomanometer), serum creatinine, electrolytes, complete blood cell counts, urine volume, drainage volume, and weekly creatinine clearance.<br>[225, 229] Systolic and diastolic BP<br>[238, 239] LVMi<br>[281, 282] LVMi<br>[299, 300] LVMi<br></td>
<td width=33%>
[9, 10] regression<br>[19, 22] arterial stiffness.<br>[38, 40] regressive effect<br>[119, 124] blood pressure (BP)<br>[147, 153] aortic and large-artery compliance<br>[154, 164] arterial wave reflections [pulse wave velocity (PWV)<br>[165, 173] augmentation index (AI) application tonometry]<br>[174, 177] cardiac echocardiography.<br>[180, 210] body weight, BP (mercury sphygmomanometer), serum creatinine, electrolytes, complete blood cell counts, urine volume, drainage volume, and weekly creatinine clearance.<br>[218, 219] measurements<br>[225, 229] Systolic and diastolic BP<br>[238, 239] LVMi<br>[281, 282] LVMi<br>[288, 291] PWV and AI.<br>[299, 300] LVMi<br>[305, 308] arterial hemodynamics.<br></td>
<td width=33%>
[9, 14] regression of left ventricular hypertrophy<br>[17, 22] reduction of arterial stiffness.<br>[38, 44] regressive effect on left ventricular hypertrophy<br>[71, 77] left ventricular mass index (LVMi<br>[118, 124] target blood pressure (BP)<br>[147, 177] aortic and large-artery compliance and arterial wave reflections [pulse wave velocity (PWV) and augmentation index (AI) application tonometry] and cardiac echocardiography.<br>[180, 210] body weight, BP (mercury sphygmomanometer), serum creatinine, electrolytes, complete blood cell counts, urine volume, drainage volume, and weekly creatinine clearance.<br>[218, 219] measurements<br>[225, 229] Systolic and diastolic BP<br>[238, 239] LVMi<br>[281, 282] LVMi<br>[286, 291] reduction in PWV and AI.<br>[298, 308] reduced LVMi in association with alterations in arterial hemodynamics.<br></td>
</tr>
